PB-432

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePB-432
Drug Alias NameCOVID-19/acute respiratory insufficiency therapeutic (G Pohl-Boskamp)PB-432
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesG. Pohl-Boskamp Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesG. Pohl-Boskamp Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A